147 related articles for article (PubMed ID: 22245096)
1. Cathepsins D and L reduce the toxicity of advanced glycation end products.
Grimm S; Horlacher M; Catalgol B; Hoehn A; Reinheckel T; Grune T
Free Radic Biol Med; 2012 Mar; 52(6):1011-23. PubMed ID: 22245096
[TBL] [Abstract][Full Text] [Related]
2. Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster.
Tsakiri EN; Iliaki KK; Höhn A; Grimm S; Papassideri IS; Grune T; Trougakos IP
Free Radic Biol Med; 2013 Dec; 65():1155-1163. PubMed ID: 23999505
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1.
Sebeková K; Schinzel R; Ling H; Simm A; Xiang G; Gekle M; Münch G; Vamvakas S; Heidland A
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1051-60. PubMed ID: 9846887
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin D is one of the major enzymes involved in intracellular degradation of AGE-modified proteins.
Grimm S; Ernst L; Grötzinger N; Höhn A; Breusing N; Reinheckel T; Grune T
Free Radic Res; 2010 Sep; 44(9):1013-26. PubMed ID: 20560835
[TBL] [Abstract][Full Text] [Related]
5. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
[TBL] [Abstract][Full Text] [Related]
6. [The lysosomal cathepsins B, L and D in development of murine experimental leukemias].
Khalikova TA; Korolenko TA; Il'nitskaia SI
Biomed Khim; 2009; 55(5):621-34. PubMed ID: 20017393
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes.
Xu B; Ji Y; Yao K; Cao YX; Ferro A
Clin Sci (Lond); 2005 Nov; 109(5):439-46. PubMed ID: 16022682
[TBL] [Abstract][Full Text] [Related]
8. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.
Mruthinti S; Sood A; Humphrey CL; Swamy-Mruthinti S; Buccafusco JJ
Neuroscience; 2006 Oct; 142(2):463-73. PubMed ID: 16890367
[TBL] [Abstract][Full Text] [Related]
9. In vitro-prepared advanced glycation end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular derived kidney epithelial cell line.
Deuther-Conrad W; Franke S; Henle T; Sommer M; Stein G
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL187-96. PubMed ID: 11936867
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.
Glenn JV; Mahaffy H; Wu K; Smith G; Nagai R; Simpson DA; Boulton ME; Stitt AW
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):441-51. PubMed ID: 18676633
[TBL] [Abstract][Full Text] [Related]
11. Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA.
Zhu P; Yang C; Chen LH; Ren M; Lao GJ; Yan L
Arch Dermatol Res; 2011 Jul; 303(5):339-50. PubMed ID: 21132435
[TBL] [Abstract][Full Text] [Related]
12. Experimental induction of AGEs in fetal L132 lung cells changes the level of intracellular cathepsin D.
Kasper M; Schinzel R; Niwa T; Münch G; Witt M; Fehrenbach H; Wilsch-Bräuninger M; Pehlke K; Hofer A; Funk RH
Biochem Biophys Res Commun; 1999 Jul; 261(1):175-82. PubMed ID: 10405342
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
Gangoiti MV; Cortizo AM; Arnol V; Felice JI; McCarthy AD
Eur J Pharmacol; 2008 Dec; 600(1-3):140-7. PubMed ID: 18973752
[TBL] [Abstract][Full Text] [Related]
14. Induction of macrophage growth by advanced glycation end products of the Maillard reaction.
Yui S; Sasaki T; Araki N; Horiuchi S; Yamazaki M
J Immunol; 1994 Feb; 152(4):1943-9. PubMed ID: 8120398
[TBL] [Abstract][Full Text] [Related]
15. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
Booth AA; Khalifah RG; Hudson BG
Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
Hodgkinson CP; Laxton RC; Patel K; Ye S
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2275-81. PubMed ID: 18818414
[TBL] [Abstract][Full Text] [Related]
17. Thermal glycation of proteins by D-glucose and D-fructose.
Kańska U; Boratyński J
Arch Immunol Ther Exp (Warsz); 2002; 50(1):61-6. PubMed ID: 11916310
[TBL] [Abstract][Full Text] [Related]
18. Protein glycation: creation of catalytic sites for free radical generation.
Yim MB; Yim HS; Lee C; Kang SO; Chock PB
Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
[TBL] [Abstract][Full Text] [Related]
19. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
20. Localization of advanced glycation end products of Maillard reaction in bovine tissues and their endocytosis by macrophage scavenger receptors.
Mori T; Takahashi K; Higashi T; Takeya M; Kume S; Kawabe Y; Kodama T; Horiuchi S
Exp Mol Pathol; 1995 Oct; 63(2):135-52. PubMed ID: 8941048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
